Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,798
Companies 1,771
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,798 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 27 of 200 · By data quality, then INN

  1. mycophenolate sodium

    MYCOPHENOLATE SODIUM Teva Pharma GmbH

    ORAL FDA: approved

  2. nadolol

    CORGARD Amneal Pharma Europe Ltd

    ORAL FDA: approved

  3. naftifine hydrochloride

    NAFTIFINE HYDROCHLORIDE Amneal Pharma Europe Ltd

    TOPICAL FDA: approved

  4. nalmefene hydrochloride

    REVEX Indivior Pty Ltd

    INTRAMUSCULAR, SUBCUTANEOUS FDA: approved

  5. naloxone hydrochloride

    NALOXONE HYDROCHLORIDE Amneal Pharma Europe Ltd

    INTRAMUSCULAR, SUBCUTANEOUS FDA: approved

  6. naltrexone

    ARX-NALTREXONE Lacuna Pharma Pty Ltd

    INTRAMUSCULAR FDA: approved · EMA: approved · TGA: approved

    A08AA

  7. naltrexone hydrochloride

    NALTREXONE HYDROCHLORIDE ELITE PHARMACEUTICALS INC /NV/

    ORAL FDA: approved

  8. nandrolone decanoate

    NANDROLONE DECANOATE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  9. naproxen

    ANAPROX 550 Amneal Pharma Europe Ltd

    ORAL FDA: approved · TGA: approved

  10. naproxen sodium

    NAPROXEN SODIUM Amneal Pharma Europe Ltd

    ORAL FDA: approved

  11. nateglinide

    TRAZEC Teva Pharma GmbH

    ORAL FDA: approved · EMA: withdrawn

    A10BX03

  12. nefazodone hydrochloride

    NEFAZODONE HYDROCHLORIDE Teva Pharma GmbH

    ORAL FDA: approved

  13. nelarabine

    ATRIANCE Amneal Pharma Europe Ltd

    INTRAVENOUS FDA: approved · EMA: approved

    L01BB07

  14. neomycin sulfate

    NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE Teva Pharma GmbH

    FOR RX COMPOUNDING FDA: approved

  15. neostigmine methylsulfate

    NEOSTIGMINE METHYLSULFATE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  16. neratinib maleate

    NERATINIB MALEATE PUMA BIOTECHNOLOGY, INC.

    ORAL FDA: approved

  17. nevirapine

    NEVIRAPINE VIATRIS Alphapharm Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    J05AG01

  18. niacin

    NIACIN Amneal Pharma Europe Ltd

    ORAL FDA: approved

  19. nicardipine hydrochloride

    NICARDIPINE HYDROCHLORIDE Regeneron Ireland Designated Activity Company (DAC)

    ORAL FDA: approved

  20. nicotine polacrilex

    NICOTINE POLACRILEX Teva Pharma GmbH

    ORAL FDA: approved

  21. nifedipine

    APO-NIFEDIPINE XR Apotex Pty Ltd

    ORAL FDA: approved · TGA: approved · NMPA: clinical trials

  22. nintedanib

    OFEV Boehringer Ingelheim Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L01EX09

  23. nitisinone

    NITYR Eton Pharmaceuticals

    ORAL FDA: approved · EMA: approved · PMDA: approved

    A16AX04

  24. nitrofurantoin

    ARX-NITROFURANTOIN Lacuna Pharma Pty Ltd

    ORAL FDA: approved · TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,798 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.